Massini G, et al. Nutritional strategies to prevent muscle loss and sarcopenia in chronic kidney disease: what do we currently know?. Nutrients, 2023; 15:14.
Moorthi RN, Avin KG (2017) Clinical relevance of sarcopenia in chronic kidney disease. Curr Opin Nephrol Hypertens 26(3):219–228
Article PubMed PubMed Central Google Scholar
Moon SJ et al (2015) Relationship between Stage of Chronic Kidney Disease and Sarcopenia in Korean Aged 40 Years and Older Using the Korea National Health and Nutrition Examination Surveys (KNHANES IV-2, 3, and V-1, 2), 2008–2011. PLoS ONE 10(6):e0130740
Article PubMed PubMed Central Google Scholar
Pavasini R et al (2016) Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis. BMC Med 14(1):215
Article PubMed PubMed Central Google Scholar
Western, M.J. and O.S. Malkowski. Associations of the Short Physical Performance Battery (SPPB) with Adverse Health Outcomes in Older Adults: A 14-Year Follow-Up from the English Longitudinal Study of Ageing (ELSA). Int J Environ Res Public Health, 2022. 19:23.
Reese PP et al (2013) Physical performance and frailty in chronic kidney disease. Am J Nephrol 38(4):307–315
Terpstra ML et al (2016) Measurement of the intestinal permeability in chronic kidney disease. World J Nephrol 5(4):378–388
Article PubMed PubMed Central Google Scholar
Meijers, B., et al., Intestinal Barrier Function in Chronic Kidney Disease. Toxins (Basel), 2018. 10:7.
Karim A et al (2021) Intestinal permeability marker zonulin as a predictor of sarcopenia in chronic obstructive pulmonary disease. Respir Med 189:106662
Ahmad F et al (2022) Plasma zonulin correlates with cardiac dysfunction and poor physical performance in patients with chronic heart failure. Life Sci 311(Pt A):121150
Article CAS PubMed Google Scholar
Karim A et al (2022) Elevated plasma zonulin and CAF22 are correlated with sarcopenia and functional dependency at various stages of Alzheimer’s diseases. Neurosci Res 184:47–53
Article CAS PubMed Google Scholar
Seethaler B et al (2021) Biomarkers for assessment of intestinal permeability in clinical practice. Am J Physiol Gastrointest Liver Physiol 321(1):G11–G17
Article CAS PubMed Google Scholar
Qaisar R et al (2024) Butyrate supplementation reduces sarcopenia by repairing neuromuscular junction in patients with chronic obstructive pulmonary disease. Respir Med 222:107510
Chen TK, Knicely DH, Grams ME (2019) Chronic Kidney Disease Diagnosis and Management: A Review. JAMA 322(13):1294–1304
Article CAS PubMed PubMed Central Google Scholar
Karim, A., T. Muhammad, and R. Qaisar, Prediction of Sarcopenia Using Multiple Biomarkers of Neuromuscular Junction Degeneration in Chronic Obstructive Pulmonary Disease. J Pers Med, 2021. 11:9.
World Medical, A. (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20):2191–2194
Cruz-Jentoft AJ et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(4):601
Article PubMed PubMed Central Google Scholar
Karim A et al (2022) Evaluation of sarcopenia using biomarkers of the neuromuscular junction in parkinson’s disease. J Mol Neurosci 72(4):820–829
Article CAS PubMed Google Scholar
Schweighofer, N., et al., DXA-Derived Indices in the Characterisation of Sarcopenia. Nutrients, 2021. 14:1.
Karim, A., et al., Elevated plasma zonulin and CAF22 are correlated with sarcopenia and functional dependency at various stages of Alzheimer's diseases. Neurosci Res, 2022.
Karim, A., et al., A multistrain probiotic reduces sarcopenia by modulating Wnt signaling biomarkers in patients with chronic heart failure. J Cardiol, 2022.
Gupta A et al (2022) SARS-CoV-2 infection- induced growth factors play differential roles in COVID-19 pathogenesis. Life Sci 304:120703
Article CAS PubMed PubMed Central Google Scholar
Qaisar, R., et al., Circulating Biomarkers of Accelerated Sarcopenia in Respiratory Diseases. Biology (Basel), 2020. 9:10.
Qi, Y., et al., Intestinal Permeability Biomarker Zonulin is Elevated in Healthy Aging. J Am Med Dir Assoc, 2017. 18(9): 810 e1–810.
Ramirez-Velez R et al (2021) Performance of the short physical performance battery in identifying the frailty phenotype and predicting geriatric syndromes in community-dwelling elderly. J Nutr Health Aging 25(2):209–217
Article CAS PubMed Google Scholar
Chen X et al (2021) Relationships between sarcopenia, depressive symptoms, and mild cognitive impairment in Chinese community-dwelling older adults. J Affect Disord 286:71–77
Delfinis, L.J., et al., Muscle weakness precedes atrophy during cancer cachexia and is linked to muscle-specific mitochondrial stress. JCI Insight, 2022. 7:24.
Kaysen GA et al (2011) Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial. Am J Kidney Dis 57(1):101–112
Article PubMed PubMed Central Google Scholar
Carpes LS et al (2021) Could serum zonulin be an intestinal permeability marker in diabetes kidney disease? PLoS ONE 16(6):e0253501
Article CAS PubMed PubMed Central Google Scholar
Mazgaeen, L. and P. Gurung, Recent Advances in Lipopolysaccharide Recognition Systems. Int J Mol Sci, 2020. 21:2.
Kotanko P, Carter M, Levin NW (2006) Intestinal bacterial microflora–a potential source of chronic inflammation in patients with chronic kidney disease. Nephrol Dial Transplant 21(8):2057–2060
Ji, Y., et al., Inflammation: Roles in Skeletal Muscle Atrophy. Antioxidants (Basel), 2022. 11:9.
Qaisar R et al (2023) ACE Inhibitors improve skeletal muscle by preserving neuromuscular junctions in patients with Alzheimer’s disease. J Alzheimers Dis 94(2):641–650
Article CAS PubMed Google Scholar
Bhaskaran S et al (2020) Neuron-specific deletion of CuZnSOD leads to an advanced sarcopenic phenotype in older mice. Aging Cell 19(10):e13225
Article CAS PubMed PubMed Central Google Scholar
Alamdari N et al (2012) Loss of muscle strength during sepsis is in part regulated by glucocorticoids and is associated with reduced muscle fiber stiffness. Am J Physiol Regul Integr Comp Physiol 303(10):R1090–R1099
Article CAS PubMed PubMed Central Google Scholar
Scheffler L et al (2018) Widely Used Commercial ELISA does not detect precursor of haptoglobin2, but recognizes properdin as a potential second member of the Zonulin family. Front Endocrinol (Lausanne) 9:22
Massier L et al (2021) Blurring the picture in leaky gut research: how shortcomings of zonulin as a biomarker mislead the field of intestinal permeability. Gut 70(9):1801–1802
Perez-Diaz-Del-Campo N et al (2023) Fecal and circulating biomarkers for the non-invasive assessment of intestinal permeability. Diagnostics (Basel) 13:11
留言 (0)